Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
Although testosterone therapy in men with testosterone deficiency was introduced in the early 1940s, utilization of this effective treatment approach in hypogonadal men is met with considerable skepticism and resistance. Indeed, for decades, the fear that testosterone may cause prostate cancer has...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Urological Association
2016-11-01
|
| Series: | Investigative and Clinical Urology |
| Subjects: | |
| Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-384.pdf |
| _version_ | 1818037923145056256 |
|---|---|
| author | Abdulmaged Traish |
| author_facet | Abdulmaged Traish |
| author_sort | Abdulmaged Traish |
| collection | DOAJ |
| description | Although testosterone therapy in men with testosterone deficiency was introduced in the early 1940s, utilization of this effective
treatment approach in hypogonadal men is met with considerable skepticism and resistance. Indeed, for decades, the fear that testosterone
may cause prostate cancer has hampered clinical progress in this field. Nevertheless, even after considerable knowledge
was acquired that this fear is unsubstantiated, many in the medical community remain hesitant to utilize this therapeutic approach
to treat men with hypogonadism. As the fears concerning prostate cancer have subsided, a new controversy regarding use of testosterone
therapy and increase in cardiovascular disease was introduced. Although the new controversy was based on one ill-fated
clinical trial, one meta-analysis with studies that utilized unapproved formulation in men with liver cirrhosis, and two retrospective
studies with suspect or nonvalidated statistical methodologies and database contaminations, the flames of such controversy were
fanned by the lay press and academics alike. In this review we discuss the adverse effect of testosterone deficiency and highlight
the numerous proven benefits of testosterone therapy on men’s health and debunk the myth that testosterone therapy increases
cardiovascular risk. Ultimately, we believe that there is considerable scientific and clinical evidence to suggest that testosterone
therapy is safe and effective with restoration of physiological levels in men with testosterone deficiency, irrespective of its etiology. |
| first_indexed | 2024-12-10T07:34:33Z |
| format | Article |
| id | doaj.art-ee2e2982c622476783fa43c669bab93d |
| institution | Directory Open Access Journal |
| issn | 2466-0493 2466-054X |
| language | English |
| last_indexed | 2024-12-10T07:34:33Z |
| publishDate | 2016-11-01 |
| publisher | Korean Urological Association |
| record_format | Article |
| series | Investigative and Clinical Urology |
| spelling | doaj.art-ee2e2982c622476783fa43c669bab93d2022-12-22T01:57:27ZengKorean Urological AssociationInvestigative and Clinical Urology2466-04932466-054X2016-11-0157638440010.4111/icu.2016.57.6.384Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?Abdulmaged Traish0Boston University School of MedicineAlthough testosterone therapy in men with testosterone deficiency was introduced in the early 1940s, utilization of this effective treatment approach in hypogonadal men is met with considerable skepticism and resistance. Indeed, for decades, the fear that testosterone may cause prostate cancer has hampered clinical progress in this field. Nevertheless, even after considerable knowledge was acquired that this fear is unsubstantiated, many in the medical community remain hesitant to utilize this therapeutic approach to treat men with hypogonadism. As the fears concerning prostate cancer have subsided, a new controversy regarding use of testosterone therapy and increase in cardiovascular disease was introduced. Although the new controversy was based on one ill-fated clinical trial, one meta-analysis with studies that utilized unapproved formulation in men with liver cirrhosis, and two retrospective studies with suspect or nonvalidated statistical methodologies and database contaminations, the flames of such controversy were fanned by the lay press and academics alike. In this review we discuss the adverse effect of testosterone deficiency and highlight the numerous proven benefits of testosterone therapy on men’s health and debunk the myth that testosterone therapy increases cardiovascular risk. Ultimately, we believe that there is considerable scientific and clinical evidence to suggest that testosterone therapy is safe and effective with restoration of physiological levels in men with testosterone deficiency, irrespective of its etiology.https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-384.pdfCardiovascular risk; Hypogonadism; Prostate cancer; Testosterone; Therapy |
| spellingShingle | Abdulmaged Traish Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Investigative and Clinical Urology Cardiovascular risk; Hypogonadism; Prostate cancer; Testosterone; Therapy |
| title | Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? |
| title_full | Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? |
| title_fullStr | Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? |
| title_full_unstemmed | Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? |
| title_short | Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? |
| title_sort | testosterone therapy in men with testosterone deficiency are we beyond the point of no return |
| topic | Cardiovascular risk; Hypogonadism; Prostate cancer; Testosterone; Therapy |
| url | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-384.pdf |
| work_keys_str_mv | AT abdulmagedtraish testosteronetherapyinmenwithtestosteronedeficiencyarewebeyondthepointofnoreturn |